生物技术与制药领域的最新动态
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
Ultima Genomics UG 100 platform vs. Illumina NovaSeq X Series whole-genome sequencing benchmarking - Illumina
Lonza Expands TheraPEAK® Portfolio to Strengthen Support for Gene and Cell Therapy Development - Lab Manager
Lonza Expands Cell and Gene Therapy Portfolio - Contract Pharma
Bioindustry Faces Talent Crunch and Regulatory Strain - GEN - Genetic Engineering and Biotechnology News
Why Top Investors Are Buying Thermo Fisher Scientific Inc. (TMO) - The Acquirer's Multiple
Lonza Announces Innovation Day at SupplySide Global - WholeFoods Magazine
Carol Mary Roche of Mequon, Wisconsin | 1944 - 2025 | Obituary - feerick funeral home
Lonza announces new board nominee - The Vacaville Reporter
Jazz Pharma, Roche's combination therapy for lung cancer gets US approval - Reuters
Where is Thermo Fisher Scientific (TMO) Headed According to Analysts? - Yahoo Finance
Agilent Technologies, Inc.'s (NYSE:A) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Yahoo Finance
Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher's N.C. production facility - Fierce Pharma
Centre for Alternate Protein Research launched at University of Hyderabad’s Aspire-BioNest - theplantbasemag.com
Why Is Illumina (ILMN) Stock Rocketing Higher Today - Yahoo Finance
Illumina launches AI informatics business for multi-omic drug discovery - Fierce Biotech
Illumina launches new business to accelerate technology and data-driven discovery - PR Newswire
Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call - Yahoo Finance
Agilent Technologies, Inc. (A) Partners With AI Firm Lunit to Advance Cancer Diagnostics - Yahoo Finance
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub - Business Wire